Premium
Nutraceuticals maker Tirupati Medicare recorded a hit in operational margin in FY23 after fluctuations last fiscal, even as the company’s outlook is expected to be stable in the medium term, it is learnt. The Himachal Pradesh-based company's EBITDA margins hovered within the range of 10-12% in the recent past but faced ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
